SINEMET CR is a prescription medication used primarily to treat symptoms of Parkinson's disease, a neurological disorder that affects movement. It is a controlled-release formulation that combines two active ingredients: carbidopa and levodopa. Levodopa is converted into dopamine in the brain, helping to improve motor function and control, while carbidopa prevents the premature conversion of levodopa into dopamine outside the brain, ensuring more levodopa reaches the brain and reducing side effects. SINEMET CR is designed to release its ingredients more slowly compared to immediate-release formulations, providing a more stable level of medication in the blood and potentially reducing fluctuations in the patient's response to the treatment. It is important for patients to follow their healthcare provider's instructions closely when taking SINEMET CR, as the dosage and timing are crucial for managing symptoms effectively. When using SINEMET CR, a medication commonly prescribed for Parkinson's disease, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you understand the correct dosage and timing for your specific condition. SINEMET CR can cause side effects that might impair your ability to drive or operate machinery safely, such as dizziness or drowsiness. Common side effects include nausea, dry mouth, and loss of appetite, while rarer side effects might involve more serious issues like hallucinations or unusual mood changes. It's also essential to inform your doctor about any other medications you're taking, as SINEMET CR can interact with them in ways that might necessitate adjustments to your treatment plan. Always prioritize communication with your healthcare provider to manage your condition effectively and safely.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.